The World Vaccine Congress Europe Story


Europe’s most successful vaccine event is now entering its 17th year.

For 16 years the World Vaccine Congress in Europe has been the leading event to talk about scientific advances and find new business opportunities within the vaccine sector and this year is no exception.

The event has grown from humble beginnings as a small conference with a handful of exhibition stands, developing each year, resulting in a brilliant 2015 congress.

This year we experienced the biggest congress yet, with approximately 350 delegates, 95 speakers and fantastic content (in combination with the Veterinary Congress Congress ).

The agenda is built to reflect the new activities in the vaccine industry, from a focus on what is going on in the immunotherapy or influenza vaccine fields to parallel tracks on discovery and pre-clinical validation, clinical trials and manufacturing methods - there is something for everyone who works within the vaccines field.

For 2016 we are building on previous success by making sure that the agenda delves into what is truly innovative in the sector right now and the speakers continue to be true disrupters and trend-setters. 

The World Vaccine Congress Europe is a place where collaborations are founded and scientific innovations are sparked. 



New vaccine technology is changing the whole industry


Make sure you are at the forefront of the vaccines industry. No matter where your interest lies, at the 16th annual World Vaccine Congress, we have content, networking and potential partners for you.

By bringing experts from the whole value chain under one roof, you get to choose the sessions which are the most applicable to help your business plan for the future of vaccine research, development and manufacture.

Take just three days out of the office to meet with 400+ potential customers who need to find solutions to challenges around the commercial and scientific issues in manufacturing, trials, strategy, regulation, respiratory, therapeutic and emerging diseases vaccines.



Optimize early formulation through to clinical manufacturing, by embracing new techniques and technologies




From new adjuvant technologies to novel immunotherapies, better understand the latest developments in the fast-evolving cancer landscape whether you are interested in cancer and immunotherapy, allergy or chronic infectious diseases



Find ways to improve development of universal influenza, RSV, MERS and Pneumococcal vaccines




Understand the opportunities for your business in reacting to global threats like malaria, dengue and Ebola




Assess how to improve your clinical trial performance, from developing novel immunological assays to creating clinical efficacy




Get involved

To exhibit, sponsor or speak at the event contact
Marc Rhys-Evans on +44 (0)20 7827 5945